Sponsor Pipeline

UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-24 NCT07725796 A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07725796 A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult… Bladder (Urothelial, Transitional Cell) Cancer Not Yet Recruiting
Disease Areas
Bladder Cancer (1)
Get alerts when UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free